Literature DB >> 6947964

Proliferative response of lymphocyte subpopulations differing in avidity for sheep red blood cells after stimulation with normal allogeneic and tumour cells.

L Matera, M R Potter, M Moore.   

Abstract

Lymphocytes from normal donors were cultured with cell lines of erythroid (K562) and lymphoid (Bri8) origin, fresh cells derived from chronic myeloid leukaemia patients (FLC), T-depleted normal peripheral blood lymphocytes (PBL) and normal bone marrow cells (NBMC). The proliferative response to these stimulator cells was evaluated in both the total lymphocyte population and in subpopulations with different affinity receptors for sheep red blood cells (SRBC), on the second, fourth and sixth days of culture. No DNA synthesis was induced by the K562 cell line, while Bri8 cells induced a proliferative response greater than that observed against PBL. No differences in the DNA synthesis pattern were observed when NBMC and FLC were used as stimulators which was comparable with that for PBL. There was a correlation between the degree of activation of the culture and the changes in size of the responding SRBC binding cell population (ET+). A progressive increase with duration of the cultures in the number of SRBC high avidity cells (EH+) and a parallel contraction of the SRBC low avidity (EL+) and E- cell populations was generally observed, so that EH+ and ET+ fractions gave similar values at the later time points. The analysis of [3H]-thymidine uptake of E+ and E- fractions on days 3 and 6, in FLC and NBMC-stimulated lymphocytes showed a prevalent involvement of E- cells on day 3, while on day 6 the majority of dividing cells belonged to the E+ compartment. A higher recruitment of E- cells in the early phase of the response was observed in FLC-stimulated lymphocytes. The participation of non-T cell populations in the proliferative response against allogeneic normal and tumour antigens is discussed.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6947964      PMCID: PMC1554994     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  24 in total

1.  Performance of a rosette assay between lymphocytes and sheep erythrocytes at elevated temperatures to study patients with cancer and other diseases.

Authors:  W H West; C W Sienknecht; A S Townes; R B Herberman
Journal:  Clin Immunol Immunopathol       Date:  1976-01

2.  The formation of stable E-rosettes by human T lymphocytes activated in mixed lymphocyte reactions.

Authors:  U Galili; M Schlesinger
Journal:  J Immunol       Date:  1976-09       Impact factor: 5.422

3.  Natural cytotoxic reactivity of human lymphocytes against a myeloid cell line: characterization of effector cells.

Authors:  W H West; G B Cannon; H D Kay; G D Bonnard; R B Herberman
Journal:  J Immunol       Date:  1977-01       Impact factor: 5.422

4.  The formation of stable E-rosettes by human T lymphocytes activated by phytohemagglutinin.

Authors:  A K Katoh; S Charoensiri
Journal:  J Immunol       Date:  1977-06       Impact factor: 5.422

5.  Surface markers on human B and T lymphocytes. IV. Distribution of surface markers on resting and blast-transformed lymphocytes.

Authors:  M Jondal
Journal:  Scand J Immunol       Date:  1974       Impact factor: 3.487

6.  Sensitization of human lymphocytes against autologous or allogeneic lymphoblastoid cell lines: characteristics of the reactive cells.

Authors:  E Svedmyr; H Wigzell; M Jondal
Journal:  Scand J Immunol       Date:  1974       Impact factor: 3.487

7.  Cytochemical identification of monocytes and granulocytes.

Authors:  L T Yam; C Y Li; W H Crosby
Journal:  Am J Clin Pathol       Date:  1971-03       Impact factor: 2.493

8.  In vitro augmentation of human natural cytotoxic activity.

Authors:  M R Potter; M Moore
Journal:  Clin Exp Immunol       Date:  1981-05       Impact factor: 4.330

9.  Properties of the K562 cell line, derived from a patient with chronic myeloid leukemia.

Authors:  E Klein; H Ben-Bassat; H Neumann; P Ralph; J Zeuthen; A Polliack; F Vánky
Journal:  Int J Cancer       Date:  1976-10-15       Impact factor: 7.396

10.  Human mixed lymphocyte culture using separated lymphocyte populations.

Authors:  M R Potter; M Moore
Journal:  Immunology       Date:  1977-03       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.